Medical Gas Plasma Promotes Apoptosis Accompanied by Immunomodulation in Gastrointestinal Tumor Cells
- 1ZIK plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany
- 2Department of Dermatology, Venerology, and Allergology, Rostock University Medical Center, Strempelstr. 13, 18057 Rostock, Germany
- 3Department of Hematology and Oncology, Greifswald University Medical Center, Sauerbruchstr., 17475 Greifswald, Germany
Abstract
Background/Objectives: Medical plasma is a promising therapeutic approach in oncology due to its ability to generate reactive oxygen and nitrogen species (RONS) and modulate tumor cell viability and phenotype. Therefore, medical plasma could expand the treatment options for highly prevalent or difficult-to-treat cancer entities such as gastrointestinal cancers. Methods: This study investigated the effects of medical plasma generated by the clinically certified argon plasma jet kINPen on two gastrointestinal tumor cell lines (HT-29, MUG-CCArly) with a focus on cytotoxicity, immunomodulation, and redox-dependent mechanisms. Results: Plasma produced a mixture of reactive species under the applied experimental conditions and was able to reduce metabolic activity and cell viability via a redox-dependent induction of apoptosis in both cell lines. Plasma exposure altered the expression of cell-surface markers with potentially immunostimulatory roles such as CD40, CRT, and HMGB1, as well as more immunoregulatory markers like CD47 and PD-L1 (CD274). Additionally, modulated secretion profiles marked by increased pro-inflammatory molecules such as IL-8 and MIP-3a (CCL20) were detected. Conclusion: Overall, congruent but also cell line-dependent responses to plasma treatment were observed that featured a modified immunological phenotype of tumor cells with potentially immunostimulatory but also immunomodulatory aspects, highlighting the potential of medical gas plasma technology as a multimodal therapeutic approach in gastrointestinal oncology.
Related
- A let-7a-5p-engineered extracellular vesicle-laden bioactive scaffold promotes immunomodulation and regeneration of segmental tracheal defects.
- p300/CBP inhibition promotes apoptosis in mouse embryos by impairing H1K75ac-associated DNA repair during the 4-cell-to-blastocyst transition
- Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: A pilot study
- Metformin promotes apoptosis of senescent chondrocytes by disrupting the Bcl-xL/Mcl-1–Bak interaction
- Leptin promotes obesity‑related osteoarthritis progression via CD44/JAK2/STAT3 axis‑mediated chondrocyte apoptosis.
BibTeX
@article{zietz2026medical,
title = {{Medical Gas Plasma Promotes Apoptosis Accompanied by Immunomodulation in Gastrointestinal Tumor Cells}},
author = {Lisa-Marie Zietz and Tino Pritzkow and Debora Singer and Alice Martinet and Lea Miebach and Sander Bekeschus},
journal = {Cancers},
year = {2026},
month = nov,
doi = {10.3390/cancers18213526},
url = {https://www.mdpi.com/2072-6694/18/21/3526},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Medical Gas Plasma Promotes Apoptosis Accompanied by Immunomodulation in Gastrointestinal Tumor Cells
AU - Lisa-Marie Zietz
AU - Tino Pritzkow
AU - Debora Singer
AU - Alice Martinet
AU - Lea Miebach
AU - Sander Bekeschus
PY - 2026
DA - 2026/11/03
JO - Cancers
DO - 10.3390/cancers18213526
UR - https://www.mdpi.com/2072-6694/18/21/3526
AB - Background/Objectives: Medical plasma is a promising therapeutic approach in oncology due to its ability to generate reactive oxygen and nitrogen species (RONS) and modulate tumor cell viability and phenotype. Therefore, medical plasma could expand the treatment options for highly prevalent or difficult-to-treat cancer entities such as gastrointestinal cancers. Methods: This study investigated the effects of medical plasma generated by the clinically certified argon plasma jet kINPen on two gastrointestinal tumor cell lines (HT-29, MUG-CCArly) with a focus on cytotoxicity, immunomodulation, and redox-dependent mechanisms. Results: Plasma produced a mixture of reactive species under the applied experimental conditions and was able to reduce metabolic activity and cell viability via a redox-dependent induction of apoptosis in both cell lines. Plasma exposure altered the expression of cell-surface markers with potentially immunostimulatory roles such as CD40, CRT, and HMGB1, as well as more immunoregulatory markers like CD47 and PD-L1 (CD274). Additionally, modulated secretion profiles marked by increased pro-inflammatory molecules such as IL-8 and MIP-3a (CCL20) were detected. Conclusion: Overall, congruent but also cell line-dependent responses to plasma treatment were observed that featured a modified immunological phenotype of tumor cells with potentially immunostimulatory but also immunomodulatory aspects, highlighting the potential of medical gas plasma technology as a multimodal therapeutic approach in gastrointestinal oncology.
SN - 2072-6694
ER -